ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 143 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $54,000 | +58.8% | 2,866 | -1.5% | 0.00% | – |
| Q2 2019 | $34,000 | -15.0% | 2,911 | -0.2% | 0.00% | – |
| Q1 2019 | $40,000 | +33.3% | 2,917 | 0.0% | 0.00% | – |
| Q4 2018 | $30,000 | -40.0% | 2,917 | -3.4% | 0.00% | – |
| Q3 2018 | $50,000 | +13.6% | 3,021 | -11.9% | 0.00% | – |
| Q2 2018 | $44,000 | 0.0% | 3,430 | 0.0% | 0.00% | – |
| Q1 2018 | $44,000 | +7.3% | 3,430 | -5.7% | 0.00% | – |
| Q4 2017 | $41,000 | +24.2% | 3,636 | +30.9% | 0.00% | – |
| Q3 2017 | $33,000 | +50.0% | 2,778 | +44.5% | 0.00% | – |
| Q2 2017 | $22,000 | +450.0% | 1,923 | +762.3% | 0.00% | – |
| Q1 2017 | $4,000 | -42.9% | 223 | -40.2% | 0.00% | – |
| Q4 2016 | $7,000 | -41.7% | 373 | 0.0% | 0.00% | – |
| Q3 2016 | $12,000 | +20.0% | 373 | 0.0% | 0.00% | – |
| Q2 2016 | $10,000 | +66.7% | 373 | +67.3% | 0.00% | – |
| Q1 2016 | $6,000 | -33.3% | 223 | -10.4% | 0.00% | – |
| Q4 2015 | $9,000 | 0.0% | 249 | 0.0% | 0.00% | – |
| Q3 2015 | $9,000 | -83.9% | 249 | -76.3% | 0.00% | -100.0% |
| Q2 2015 | $56,000 | +93.1% | 1,049 | +4.9% | 0.00% | 0.0% |
| Q1 2015 | $29,000 | -87.1% | 1,000 | -87.1% | 0.00% | -80.0% |
| Q4 2014 | $225,000 | +1945.5% | 7,750 | +811.8% | 0.01% | – |
| Q3 2014 | $11,000 | -91.7% | 850 | -87.1% | 0.00% | -100.0% |
| Q2 2014 | $132,000 | – | 6,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $40,160,000 | 10.45% |
| Foresite Capital Management II, LLC | 1,586,220 | $21,652,000 | 9.78% |
| DAFNA Capital Management LLC | 571,013 | $7,794,000 | 3.36% |
| Redmile Group, LLC | 8,244,896 | $112,543,000 | 3.29% |
| Lion Point Capital, LP | 1,271,500 | $17,355,000 | 1.57% |
| Palo Alto Investors LP | 1,861,630 | $25,411,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,185,983 | $43,488,000 | 1.03% |
| Bellevue Group AG | 1,286,748 | $17,564,000 | 0.97% |
| BB BIOTECH AG | 2,766,008 | $37,756,000 | 0.95% |
| Rock Springs Capital Management LP | 1,560,000 | $21,294,000 | 0.82% |